Walvax GSK Biotech Joint Venture Nearly Ready For Business
This article was originally published in PharmAsia News
Executive Summary
Jiangsu Walvax GSK Biotech, a joint venture between GlaxoSmithKline and Jiangsu Walvax Biotech, will soon finish construction of its Taizhou Medical City facility